摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,3,5,7a-四氢-1H-吡咯烷 | 51463-41-3

中文名称
2,3,5,7a-四氢-1H-吡咯烷
中文别名
——
英文名称
2,3,5,7a-tetrahydro-1H-pyrrolizine
英文别名
1,2,5,8-Tetrahydro-3H-pyrrolizine;1,2-dehydropyrrolizidine;2,3,5,8-tetrahydro-1H-pyrrolizine
2,3,5,7a-四氢-1H-吡咯烷化学式
CAS
51463-41-3
化学式
C7H11N
mdl
MFCD09030904
分子量
109.171
InChiKey
CSNWPSHAZNPDBA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1
  • 重原子数:
    8
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.714
  • 拓扑面积:
    3.2
  • 氢给体数:
    0
  • 氢受体数:
    1

安全信息

  • 海关编码:
    2933990090

SDS

SDS:c569264fb588efeb35f7f76048f3cc73
查看

反应信息

  • 作为反应物:
    描述:
    2,3,5,7a-四氢-1H-吡咯烷吡啶氢氧化钾硫酸potassium carbonateN-溴代乙酰胺 作用下, 以 甲醇乙醚氯仿 为溶剂, 反应 77.25h, 生成 1α,2α-epithiopyrrolizidine
    参考文献:
    名称:
    Wrobel, Jerzy Tadeusz; Glinski, Jan Adam, Canadian Journal of Chemistry, 1981, vol. 59, p. 1101 - 1104
    摘要:
    DOI:
  • 作为产物:
    参考文献:
    名称:
    α-(的反应Ñ氨甲酰基)与炔底物alkylcuprates:合成路线到α-氨基丙二烯和Δ 3 -Pyrrolines
    摘要:
    氨基甲酸酯去质子化,然后用CuCN·2LiCl处理,得到α-(N-氨基甲酰基)烷基铜酸酯,它们与炔丙基卤,甲磺酸酯,甲苯磺酸酯,磷酸盐,乙酸酯和环氧化物反应,通过抗S N生成α-(N-氨基甲酰基)丙二烯。2'替代过程。炔丙基卤化物,磺酸盐和磷酸盐给出的氨基甲酰基烯丙基烯的收率高,而乙酸酯的收率低。炔丙基底物在没有严重空间位阻的情况下进行区域特异性S N 2'取代。α-(ñ -氨基甲酰基)丙二烯环化,可以-2-恶唑烷酮或脱保护,得到其可以被环化至Δ游离胺3个-pyrrolines与任一的AgNO 3或Ru3(CO)12。
    DOI:
    10.1021/jo0481405
点击查看最新优质反应信息

文献信息

  • Spiropyrazine derivatives as inhibitors of non-apoptotic regulated cell-death
    申请人:Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
    公开号:US10647687B2
    公开(公告)日:2020-05-12
    The present invention relates to spiropyrazine compounds which are inhibitors of non-apoptotic regulated cell death, and to pharmaceutical compositions containing such compounds. Furthermore, the present invention relates to the use of such compounds and pharmaceutical compositions in therapy, in particular in the treatment of a condition, disorder or disease that is characterised by non-apoptotic regulated cell-death or where non-apoptotic regulated cell-death is likely to play or plays a substantial role. The compounds and pharmaceutical compositions described herein are also useful in the treatment of a condition, disorder or disease that is characterised by oxidative stress or where oxidative stress is likely to play or plays a substantial role; and/or a condition, disorder or disease that is characterised by activation of (1) one or more components of the necrosome; (2) death domain receptors; and/or (3) Toll-like receptors; and/or (4) players in ferroptotic/ferroptosis signalling, or where activation of any one of (1) to (3) and/or (4) is likely to play or plays a substantial role.
    本发明涉及作为非凋亡调节细胞死亡抑制剂的螺吡嗪化合物,以及含有此类化合物的药物组合物。此外,本发明还涉及此类化合物和药物组合物在治疗中的用途,特别是在治疗以非凋亡调节性细胞死亡为特征或非凋亡调节性细胞死亡可能起作用或起重要作用的病症、紊乱或疾病中的用途。本文所述的化合物和药物组合物还可用于治疗以氧化应激为特征的病症、紊乱或疾病,或氧化应激可能起作用或起重要作用的病症、紊乱或疾病;和/或(1)坏死体的一种或多种成分;(2)死亡结构域受体;和/或(3)Toll 样受体;和/或(4)变态反应/变态反应信号的参与者,或(1)至(3)和/或(4)中任何一种的激活可能起或起重要作用的情况、紊乱或疾病。
  • Acetylenes as potential antarafacial components in concerted reactions. Formation of pyrroles from thermolyses of propargyl amines, of a dihydrofuran from a propargylic ether, and of an ethylidenepyrrolidine from a .beta.-amino acetylene
    作者:Alfred Viola、John J. Collins、Nicholas Filipp、John S. Locke
    DOI:10.1021/jo00071a015
    日期:1993.9
    A thermal cyclization of acetylenic compounds provides evidence for the ability of acetylenic links to act as antarafacial components in [2 + 2] processes. The cyclization competes with the normally favored acetylenic retro-ene reaction. Propargylic amines, without substituents whose presence would hinder a tight cyclic transition state, yield intermediate pyrrolines whose subsequent hydrogen elimination affords pyrroles in small amounts. The same process in 2-ethynyltetrahydropyran affords 8-oxabicyclo[3.2.1]octane in 35% yield. A related thermal reaction of N-methyl-3-hexyn-1-amine provides a quantitative transformation to N-methyl-2-ethylidenepyrrolidine in a nominal [2s + 2a + 2s + 2s] Mobius process, wherein the acetylenic unit is the antarafacial component. Evidence for concertedness in these reactions is discussed.
  • Synthesis of 3-Pyrrolines, Annulated 3-Pyrrolines, and Pyrroles from α-Amino Allenes
    作者:R. Karl Dieter、Huayun Yu
    DOI:10.1021/ol016654+
    日期:2001.11.1
    [GRAPHICS]alpha -Amino allenes, readily prepared from reaction of alpha-(N-carbamoyl)alkylcuprates with propargyl substrates followed by N-Boc deprotection, are converted in high yields to pyrrolines with AgNO3. Palladium-catalyzed cyclization of amino allenes affords either the pyrroline or the pyrrole depending on reaction conditions and provides for introduction of an aryl substituent at the C-3 position of the pyrroline or pyrrole. Enantioenriched pyrrolines are readily prepared from scalemic propargyl alcohols.
  • Topological selectivity in the intramolecular [4 + 1] pyrroline annulation. Formal total stereospecific synthesis of (.+-.)-supinidine, (.+-.)-isoretronecanol, and (.+-.)-trachelanthamidine
    作者:Tomas. Hudlicky、James O. Frazier、Gustavo. Seoane、Mark. Tiedje、Ana. Seoane、Lawrence D. Kwart、Chris. Beal
    DOI:10.1021/ja00273a033
    日期:1986.6
  • SPIROPYRAZINE DERIVATIVES AS INHIBITORS OF NON-APOPTOTIC REGULATED CELL-DEATH
    申请人:Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
    公开号:EP3217982A1
    公开(公告)日:2017-09-20
查看更多

同类化合物

野百合碱 N-氧化物 野百合碱 螺[环氧乙烷-2,1'-吡咯里嗪] 脱氢野百合碱 矮陀陀酰胺碱 盐酸西那西林 灰毛束草碱 毛束草碱N-氧化物 毛束草碱 暗黄猪屎豆碱 去氢毛果天芥菜碱 去氢天芥菜碱 去氢倒千里光裂碱 去氢倒千里光裂碱 去氢倒千里光碱 克拉沙霉素B 克拉沙霉素A N-甲基-N-[(2R,3R,3aS,4S,6alphaS)-2,3,3a,6alpha-四氢-2,4-甲桥-4H-呋喃并[3,2-b]吡咯-3-基]-乙酰胺 N-(3-羟基-2,4-二甲基苯基)乙酰胺 8-氧杂-5-氮杂三环[5.1.1.01,5]壬-2,6-二烯 8-氧杂-2-氮杂三环[5.2.1.02,6]癸-1(9),3,5-三烯 7-羟基-6,7-二氢-5H-吡咯里嗪-1-甲醛 7-(羟基甲基)-3H-吡咯里嗪-3-酮 7-(甲氧基羰基)-6,7-二氢-5H-吡咯啉-1-羧酸 5H-吡咯并[2,1-a]异吲哚,5a,6,7,8-四氢- 3H-吡咯里嗪-3,5(2H)-二硫酮 3-甲酰基-5,6,7,8-四氢中氮茚-2-羧酸 3-氨基-N-[2,5-二氢-5-羰基-1-(2,4,5-三氯苯基)-1H-吡唑-4-基]苯酰胺 3-氧代吡咯里嗪-2-羧酸乙酯 3-氧代-3H-吡咯里嗪-2-甲酰氯 3-氧代-2,3-二氢-1H-吡咯里嗪-5-羧酸 3-氧代-2,3,5,7a-四氢-1H-吡咯里嗪-7-甲醛 3-氧-3氢-吡咯嗪-2-甲酸 3-(2,6-二乙酰基-3,7-二甲基-5H-吡咯里嗪-1-基)丙酸 2H,3H-氧杂环丁烷并[2,3-a]吡咯里嗪 2-(6-乙基-2,3-二氢-1H-吡咯里嗪-1-基)苯胺 2,5-二(叔-壬基二硫代)-1,3,4-噻二唑 2,3-二氢-7-甲基-1H-吡咯里嗪-1-酮 2,3-二氢-7-(羟基甲基)-1H-吡咯里嗪-1-酮 2,3-二氢-1H-吡咯里嗪-7-羧酸 2,3-二氢-1H-吡咯里嗪-7-甲醇 2,3-二氢-1H-吡咯里嗪-7-甲腈 2,3-二氢-1H-吡咯里嗪-1-胺 2,3-二氢-1H-吡咯里嗪-1-甲腈 2,3-二氢-1H-吡咯嗪-5-甲醛 2,3-二氢-1H-吡呤-1,7-二羧酸 2,3-二氢-(6ci,7ci,8ci,9ci)-1H-吡咯里嗪-1-酮 2,3,5,7a-四氢-1H-吡咯烷 2,2-二氯-1-(3H-吡咯里嗪-5-基)乙酮 1H-吡咯里嗪-2(3H)-酮